Funds holding ASCENTAGE PHARMA GROUP INTERNATIONAL
1 fund declares a position · 0 ETFs and 1 other funds · 8.5K $ · US04390B1052
Other lines from the same issuer : Ascentage Pharma Group International (KYG0519B1023)
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 361 | 8.5K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
6 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Point72 Asset Management, L.P. | 16,056 | 383.3K $ | as of Mar 31, 2026 |
| XY Capital Ltd | 13,014 | 310.6K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 518 | 12.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 498 | 11.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 124 | 3K $ | as of Mar 31, 2026 |
| EverSource Wealth Advisors, LLC | 24 | 573 $ | as of Mar 31, 2026 |